Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.16%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +36.53%
#5 RedStone RedStone +28.90%
#6 Humanity Humanity +26.35%
#7 Codatta Codatta +22.55%
#8 Walrus Walrus +19.98%
#9 The Black Bull The Black Bull +17.02%
#10 Enso Enso +16.70%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Trimurthi Limited Trimurthi Limited

Trimurthi Limited

TRIMURTHI
Classement en actions #36550
Trimurthi Limited functions as a parent company primarily engaged in the... Trimurthi Limited functions as a parent company primarily engaged in the pharmaceutical sector, encompassing the distribution, retail, and promotion of various medical products. Its business operations are structured across several divisions, including its core pharmaceutical ventures, financial services, investment activities, and equity trading. The company's product portfolio features medicines for family planning, women's health (obstetrics and gynecology), gastrointestinal conditions, and other therapeutic areas. Established on December 13, 1994, its corporate headquarters are situated in Hyderabad, India.
Prix de l'action
$0.31247377
Dernière synchronisation: 2025-04-21
Capitalisation boursière
$2.56M
Changement (1 jour)
0.67%
Changement (1 an)
0.00%
Pays
IN
Échange Trimurthi Limited (TRIMURTHI)

Catégorie

Healthcare
Ratio P/S pour Trimurthi Limited (TRIMURTHI)
Ratio P/S au August 2026 TTM : 0.61
Selon les derniers rapports financiers et le cours de l'action de Trimurthi Limited, le ratio cours/ventes actuel (TTM) est 0.61. À la fin de 2024, le ratio P/S était de 4.24.
Historique du ratio P/S pour Trimurthi Limited de 2008 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 0.61 -28.76%
2025 0.86 -79.69%
2024 4.24 -18.36%
2023 5.19 -39.23%
2022 8.54 1,341.37%
2021 0.59 286.25%
2020 0.15 -73.26%
2019 0.57 1.88%
2018 0.56 -18.35%
2017 0.69 -43.88%
2016 1.23 12.64%
2015 1.09 17.17%
2014 0.93 -54.87%
2013 2.06 77.76%
2012 1.16 18.31%
2011 0.98 -87.87%
2010 8.09 315.89%
2009 1.94 620.64%
2008 0.27 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 1,571.76%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 2,330.85%
US